Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug by Alan G. Ramsay, John G. Gribben

Get full text

Blocking autophagy prevents bortezomib-induced NF-κB activation by reducing I-κBα degradation in lymphoma cells. by Li Jia, Ganga Gopinathan, Johanna T Sukumar, John G Gribben

Get full text

Catching up with solid tumor oncology: what is the evidence for a prognostic role of programmed cell death-ligand 1/programmed cell death-1 expression in B-cell lymphomas? by Fabienne McClanahan, Thomas G. Sharp, John G. Gribben

Get full text

Programmed cell death protein-1 (PD1) expression in the microenvironment of classical Hodgkin lymphoma is similar between favorable and adverse outcome and does not enrich over ser... by Joseph G. Taylor, Andrew Clear, Maria Calaminici, John G. Gribben

Get full text

Mutational patterns along different evolution paths of follicular lymphoma by Miri Michaeli, Emanuela Carlotti, Helena Hazanov, John G. Gribben, Ramit Mehr

Get full text

Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next? by John G. Gribben, Elisabeth de Vries, Nathan I. Cherny, Pieter Sonneveld

Get full text

PDL1 shapes the classical Hodgkin lymphoma microenvironment without inducing T-cell exhaustion by Joseph G. Taylor, Edward Truelove, Andrew Clear, Maria Calaminici, John G. Gribben

Get full text

Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse by Silvia Montoto, Janet Matthews, Paul Greaves, Debra Lillington, Deborah Anderson, John G. Gribben, T. Andrew Lister

Get full text

B-cell Receptor Signaling Induced Metabolic Alterations in Chronic Lymphocytic Leukemia Can Be Partially Bypassed by TP53 Abnormalities by Katarina Kluckova, Andrew J. Clear, Annalisa D’Avola, Laura Z. Rassenti, Thomas J. Kipps, John G. Gribben, John C. Riches

Get full text

An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA by Kai Rejeski, Raffaella Greco, Francesco Onida, Isabel Sánchez-Ortega, Chiara Bonini, Anna Sureda, John G. Gribben, Ibrahim Yakoub-Agha, Marion Subklewe

Get full text

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn’s Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune D... by Alan Graham Pockley, James O. Lindsay, Gemma A. Foulds, Sergio Rutella, John G. Gribben, Tobias Alexander, Tobias Alexander, John A. Snowden

Get full text

The prognostic value of POD24 in relapsed/refractory follicular lymphoma—A SCHOLAR‐5 analysis by Eve H. Limbrick‐Oldfield, Steve Kanters, Markqayne D. Ray, Timothy Best, Madhu Palivela, Sara Beygi, Anik R. Patel, John G. Gribben, Paola Ghione

Get full text

Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways by Jennifer Edelmann, Arran D. Dokal, Emma Vilventhraraja, Karlheinz Holzmann, David Britton, Tetyana Klymenko, Hartmut Döhner, Mark Cragg, Andrejs Braun, Pedro Cutillas, John G. Gribben

Get full text

Real‐world outcomes of patients with relapsed/refractory large B‐cell lymphoma receiving second‐line therapy in England by Christopher P. Fox, William Townsend, John G. Gribben, Tobias Menne, Nagesh Kalakonda, Paula Williams, Farah Toron, Emma Tyas, Miranda Cooper, Joshua Rickards, John Radford

Get full text

Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors by Emily A. Saunderson, Peter Stepper, Jennifer J. Gomm, Lily Hoa, Adrienne Morgan, Michael D. Allen, J. Louise Jones, John G. Gribben, Tomasz P. Jurkowski, Gabriella Ficz

Get full text

Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes by Rinako Nakagawa, Milica Vukovic, Anuradha Tarafdar, Emilio Cosimo, Karen Dunn, Alison M. McCaig, Ailsa Holroyd, Fabienne McClanahan, Alan G. Ramsay, John G. Gribben, Alison M. Michie

Get full text

Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in MiceSummary by Francesca R. Delvecchio, Rachel E.A. Fincham, Sarah Spear, Andrew Clear, Marina Roy-Luzarraga, Frances R. Balkwill, John G. Gribben, Michele Bombardieri, Kairbaan Hodivala-Dilke, Melania Capasso, Hemant M. Kocher

Get full text

Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as... by Rita Coutinho, Andrew J. Clear, Emanuele Mazzola, Andrew Owen, Paul Greaves, Andrew Wilson, Janet Matthews, Abigail Lee, Rute Alvarez, Maria Gomes da Silva, José Cabeçadas, Donna Neuberg, Maria Calaminici, John G. Gribben

Get full text

High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution. by Emanuela Carlotti, David Wrench, Guglielmo Rosignoli, Jacek Marzec, Ajanthah Sangaralingam, Lena Hazanov, Miri Michaeli, Simon Hallam, Tracy Chaplin, Sameena Iqbal, Maria Calaminici, Bryan Young, Ramit Mehr, Peter Campbell, Jude Fitzgibbon, John G Gribben

Get full text

Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin by Claudia Dürr, Bola S. Hanna, Angela Schulz, Fabienne Lucas, Manuela Zucknick, Axel Benner, Andrew Clear, Sibylle Ohl, Selcen Öztürk, Thorsten Zenz, Stephan Stilgenbauer, Min Li-Weber, Peter H. Krammer, John G. Gribben, Peter Lichter, Martina Seiffert

Get full text